Rosenberg Matthew Hamilton Unity Biotechnology, Inc. Transaction History

Rosenberg Matthew Hamilton

  • $378 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023
SELL
$2.12 - $4.17 $3,816 - $7,506
-1,800 Reduced 90.0%
200 $0
Q1 2021

Apr 30, 2021
BUY
$5.51 - $9.42 $11,020 - $18,840
2,000 New
2,000 $12,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $16.1M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email